Equity / Investment · GCC · Announced 14 Jan 2026
Gulf Pharmaceutical Industries and Medical Devices → Khazaen Economic City
Gulf Pharmaceutical Industries and Medical Devices Corporation signed an investment agreement with Khazaen Economic City for an integrated human-medicines plant on 10,000 m², with RO 15 million (about US$39 million) for Phase 1.
Parties: Gulf Pharmaceutical Industries and Medical Devices Corporation (GPIMC) → Khazaen Economic City (Oman)
- Deal type
- Equity / Investment
- Value
- $39m
- Territory
- Oman – Khazaen Economic City (Medicine City)
- Therapeutic area
- Multi-therapy
- Asset
- Pharmaceutical manufacturing plant
- Announced
- 14 Jan 2026
Our analysis
Why this matters
Khazaen Economic City signed an investment agreement on 14 January 2026 with Gulf Pharmaceutical Industries and Medical Devices Corporation LLC (GPIMC) to build a pharmaceutical plant in its Medicine City. Phase 1 covers about 10,000 m² with an initial investment of RO 15 million (about US$39 million). Ministry of Health officials attended the signing.
The plant is planned as a fully integrated human-medicines facility covering injectables, tablets, capsules, syrups, suspensions, nasal sprays, powders and granules, creams and ointments, and certain antibiotic powders for injection, with in-house primary and secondary packaging. With this project, the Oman Observer put total investment in the Medicine City cluster at about RO 175 million.
The full analysis is free to read with a work email on this page.
Source: Oman Observer